1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > The Zika Virus Report: Implications of the Rapid Spread of Zika with a Focus on the Infectious Disease Diagnostics Market and Human Vaccines Market

Report Details
What can be expected as the Zika outbreak progresses? Which areas are going to be the most affected? This visiongain report discusses the future direction of the Zika virus outbreak and the implications of its spread. It also discussed the infectious disease diagnostics market and the global human vaccines market, both of which are forecast to 2026. The pipeline for Zika virus diagnostics and vaccines is explored.

Our 78-page report provides 28 tables, charts, and graphs. Understand the virus and the future of the current outbreak. Our new study lets you assess the impact the virus might have on a number of regions, and the complications that have so far been associated with it.

Forecasts from 2016-2026 and other analyses show you commercial prospects
This report provides forecasts for both the infectious disease diagnostics market and the human vaccines market to 2026, and discussed the possible future contributors to these markets in relation to the Zika virus. Discover the symptoms, transmission, history and economic and social impacts of this virus.

See revenue forecasts for the associated markets
How will associated markets perform to 2026? Our study forecasts revenues in the following related markets:
- Infectious Disease Diagnostics Market
- Global Vaccines Market

Leading Vaccine Manufacturers and Companies Searching for a Zika Virus Vaccine
The number of patients infected with the Zika virus is predicted to soar, and the need for a vaccine is becoming ever more apparent. We discuss some of the leading international vaccine manufacturing companies, and then take a look at the companies that are currently developing vaccines or the Zika virus.

Companies included in this report include:
- GlaxoSmithKline
- Merck
- Pfizer
- Sanofi
- Bharat Biotech
- Inovio Pharmaceuticals

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What does the Zika virus outbreak mean for the future?
Our new report discusses issues and events regarding the Zika virus outbreak, currently in Central and South America. You will find discussions, including analysis of past outbreaks, the virus’ modes of transmission, symptoms. Future trends include:
- Increasing economic and social pressures related to the virus
- Development of a vaccine will lead to large financial returns
- The virus is likely to spread from its current territories, to include the US and possibly much of Southern Europe, Africa and Asia.

How the Zika Virus Report report helps you
In summary, our 78-page report gives you the following knowledge:
- Understanding of the structure, replication mechanisms and transmission modes of the Zika virus
- An in-depth history of previous Zika virus outbreaks and detail the viruses spread from Africa
- Study of the potential spread of the virus, looking at the areas in which the virus’ vectors are able to survive on a global scale
- Intelligence on important markets that will be affected by the Zika virus outbreak
- Revenue forecast for the Infectious Disease Diagnostics Market covering the period 2016 to 2026
- Revenue forecast for the Global Vaccines Market covering the period 2016 to 2026.
- Profiles of leading companies operating within the vaccines market
- Significant social and economic issues arising from the spread of the Zika virus
- Conclusions and recommendations

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the cholesterol-lowering drugs market and leading companies. You will find data, trends and predictions. Please order our report now.

Table Of Contents

The Zika Virus Report: Implications of the Rapid Spread of Zika with a Focus on the Infectious Disease Diagnostics Market and Human Vaccines Market
1. Report Overview
1.1 Overview of Findings
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered By This Analytical Report
1.5 Who Is This Report For?
1.6 Structure of the Report
1.7 Research and Analysis Methods
1.8 Exchange Rates
1.9 Frequently Asked Questions
1.10 Associated Visiongain Reports
1.11 About Visiongain

2. Introduction to Zika Virus
2.1 The Zika Virus
2.1.1 Flavivirus Structure
2.1.2 Zika Virus Replication Mechanism
2.1.3 Modes of Transmission
2.2 Outline of Previous Zika Outbreaks
2.3 Symptoms of ZIVD
2.3.1 Microcephaly

3. Zika Outbreak 2015/2016
3.1 The Progression of Zika in the Americas
3.2 Areas at Risk from Zika Infection
3.2.1 Areas with Ae.aegypti Populations
3.2.2 Areas with Ae.albopictus Populations
3.3 Containment Measures
3.3.1 Efforts in Affected Countries
3.3.2 Efforts in Un-Affected Countries
3.4 Basic Reproductive Number
3.4.1 Related Virus Basic Reproduction Numbers

4. Diagnostic Tools for the Detection of Zika Virus
4.1 The Infectious Disease Diagnostics Market
4.2 Infectious Disease Diagnostics Market Forecast, 2016-2026
4.3 Diagnosis of Zika Infection
4.3.1 Laboratory Tests for the Diagnosis of Zika Virus Disease
4.3.2 Commercial and Point-of-Care Tests
4.3.2.1 Biocan Diagnostics

5. Zika Virus Vaccine: Pipeline Candidates
5.1 Global Vaccine Market, 2014
5.2 Global Vaccine Market Forecast, 2016-2026
5.3 Leading Manufacturers of Human Vaccines
5.3.1 GlaxoSmithKline (GSK)
5.3.2 Merck and Co (MSD)
5.3.3 Sanofi
5.3.4 Pfizer
5.4 No Zika Virus Vaccine Currently Available
5.5 Zika Virus Vaccine Pipeline
5.5.1 Bharat Biotech
5.5.2 Sanofi Pasteur
5.5.3 Inovio Pharmaceuticals
5.5.4 Other Companies

6. Economic and Socio-Economic Effects of the Zika Virus Outbreak
6.1 Overview of Impact on Affected Nations
6.2 Zika Virus and Pregnancy in Affected Countries
6.3 Tourism and Major Events
6.3.1 Comparison with Other Viral Epidemics - Ebola Outbreak 2014
6.4 Healthcare Services and Support
6.5 Predicted Impact of Further Spread

7. Glossary

List of Tables
Table 1.1 Currency Exchange Rates, 2015
Table 2.1 Modes of Infection of the Zika Virus and Their Confirmation Status
Table 2.2 Number of Live Births (000's) For a Selection of Countries in the Affected Region, 2011
Table 3.1 Countries/Territories with Active Zika Transmission as of 11th February 2016
Table 4.1 The Infectious Disease Testing Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2014-2026
Table 5.1 The Global Vaccines Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2014-2025
Table 6.1 Countries at Risk of Infection and Number of Tourists (millions), 2013
Table 6.2 Number of Live Births in US States at High and Low Risk of Active Zika Transmission, and the Percentage of Live Births of Each (%)
Table 6.3 Number of Live Births in US States at High Risk of Active Zika Transmission, 2014

List of Figures
Figure 2.1 Representation of the Structure of a Flavivirus
Figure 2.2 Representation of the Genome of a Flavivirus
Figure 2.3 The Federated States of Micronesia, Location of 2007 Zika Virus Outbreak, with Yap Island Highlighted
Figure 2.4 Map of Pacific Islands, with Area of French Polynesia Highlighted
Figure 2.5 A Comparison of the Head Size of an Infant with Microcephaly and Without
Figure 2.6 Cases of Suspected Microcephaly in Brazil from 2011 to 2016
Figure 3.1 Location of Camaçari, Brazil, First Location to Report Zika Virus in the Americas
Figure 3.2 Population Density Map of Brazil, with Major Cities Labelled
Figure 3.3 Areas Showing Zika Virus Transmission, December 2015 and January 2016, excluding Pacific Islands
Figure 3.4 Likelihood of Occurrence of Ae.aegypti across the Americas
Figure 3.5 Likelihood of Occurrence of Ae.aegypti across Europe and Africa
Figure 3.6 Likelihood of Occurrence of Ae. aegypti across the Asia-Pacific
Figure 3.7 Likelihood of Occurrence of Ae.albopictus across the Americas
Figure 3.8 Likelihood of Occurrence of Ae.albopictus across Europe and Africa
Figure 3.9 Likelihood of Occurrence of Ae.albopictus across the Asia-Pacific
Figure 4.1 The Infectious Disease Testing Market Forecast: Revenue ($bn) and AGR (%), 2014-2026
Figure 4.2 Pan American Health Organization Zika Diagnosis Advice, 2015
Figure 5.1 The Global Vaccines Market Forecast: Revenue ($bn) and AGR (%), 2014-2025
Figure 6.1 Percentage of Live US Births That Occurred in States with a High Risk and Low Risk of Active Zika Transmission, 2014


Companies Listed
Baxter
Bharat Biotech
CSL
GeneOne Life Sciences
GlaxoSmithKline
GlaxoWellcome
Inovio Pharmaceuticals
Merck
Novarits
Pfizer
Regulus Therapeutics
Sanofi
SmithKline Beecham
Takeda Pharmaceuticals

List of Organisations
Centre for Disease Control
European Centre for Disease Prevention and Control
Federation Internationale de Football Association (FIFA)
Pan American Health Organisation
The Catholic Church
World Health Organisation

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.